Compare MXL & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXL | PGNY |
|---|---|---|
| Founded | 2003 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 1.4B |
| IPO Year | 2009 | 2019 |
| Metric | MXL | PGNY |
|---|---|---|
| Price | $68.51 | $18.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $31.67 | $26.50 |
| AVG Volume (30 Days) | ★ 4.1M | 1.2M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.08 | 14.04 |
| EPS | N/A | ★ 0.65 |
| Revenue | $478,596,000.00 | ★ $1,288,661,000.00 |
| Revenue This Year | $22.10 | $8.87 |
| Revenue Next Year | $10.70 | $9.76 |
| P/E Ratio | ★ N/A | $28.30 |
| Revenue Growth | N/A | ★ 10.40 |
| 52 Week Low | $10.07 | $16.10 |
| 52 Week High | $63.52 | $28.75 |
| Indicator | MXL | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 84.04 | 55.46 |
| Support Level | $15.30 | $18.01 |
| Resistance Level | N/A | $18.79 |
| Average True Range (ATR) | 4.98 | 0.59 |
| MACD | 4.15 | 0.19 |
| Stochastic Oscillator | 94.59 | 77.95 |
MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.